The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2- phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats

Joshua S. Beckmann, Kiran B. Siripurapu, Justin R. Nickell, David B. Horton, Emily D. Denehy, Ashish Vartak, Peter A. Crooks, Linda P. Dwoskin, Michael T. Bardo

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2- phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience